Cancer Headlines from Johns Hopkins (with audio)
(MedPage Today) -- This month's topics include long-term follow-up on finasteride and dutasteride, lung cancer and air pollution, molecular reclassification of brain tumors, and a decision on cells from Henrietta Lacks. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 4, 2013 Category: Hematology Source Type: news
New Finasteride Study: What Does It Mean?New Finasteride Study: What Does It Mean?
Long-term results from the Prostate Cancer Prevention Trial raise new questions for clinicians to discuss with their patients, reports Dr. Gerald Chodak. Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 23, 2013 Category: Consumer Health News Tags: Urology Commentary Source Type: news
PodMed: A Medical News Roundup from Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include early heart valve surgery, who benefits from CRT, finasteride for prostate cancer prevention, and thalotomy for essential tremor. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 16, 2013 Category: Cardiology Source Type: news
Prostate Cancer Prevention Trial: Long-Term Follow-Up
The long-term follow-up of the Prostate Cancer Prevention Trial confirms that finasteride reduces the risk of low-grade prostate cancer by one-third, but there were no significant survival differences between the two study arms. (Source: Cancer Network)
Source: Cancer Network - August 16, 2013 Category: Cancer & Oncology Source Type: news
Reducing prostate cancer risk safely with finasteride
A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research Center confirms that a drug shown to reduce risk of prostate cancer by more than a third has no impact on lifespan but further reduces the risk of prostate cancer. Reducing the risk of prostate tumors by about 30 percent - and low-grade tumors by 43 percent - means thousands of men can avoid a cancer diagnosis and subsequent treatments that significantly affect quality of life, said Ian M. Thompson Jr., M.D... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 16, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
Baldness drug protects against prostate cancer in study
Finasteride, also sold as baldness drug Propecia, reduced men's prostate cancer risk by 30 percent (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 15, 2013 Category: Consumer Health News Source Type: news
Drug safely cuts prostate cancer risk, study finds (Associated Press, 14 August 2013)
An 18 year follow-up study from the US, published in New England Journal of Medicine, assesses prostate cancer incidence and mortality rates when using finasteride as a preventative medicine vs placebo.
Full article (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 15, 2013 Category: Endocrinology Source Type: news
Finasteride Lowers Risk for Prostate Cancer, But Offers No Mortality Advantage (FREE)
By Joe Elia
Finasteride reduces the risk for developing prostate cancer, but it may be linked to more high-grade cancers and offers no mortality benefit, according to an updated New England Journal of Medicine study.Researchers did … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 15, 2013 Category: Primary Care Source Type: news
18-Year Study Finds Drug Cut Prostate Cancer Risk
Follow-up focused on finasteride, the active ingredient in Proscar and hair-loss drug Propecia (Source: WebMD Health)
Source: WebMD Health - August 14, 2013 Category: Consumer Health News Source Type: news
18-Year Study Finds Drug Cut Prostate Cancer Risk
Follow-up focused on finasteride, the active ingredient in Proscar and hair-loss drug Propecia (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 14, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Oncology, Pharmacy, Reproductive Medicine, Urology, News, Source Type: news
Chemoprevention for Prostate Cancer: New DataChemoprevention for Prostate Cancer: New Data
Finasteride reduced the risk for prostate cancer by a third, but new long-term data show no survival difference between the drug and placebo. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 14, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Finasteride saves men from prostate cancer, doesn't increase risk of death
(University of Texas Health Science Center at San Antonio) A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research Center confirms that a drug shown to reduce risk of prostate cancer by more than a third has no impact on lifespan but further reduces the risk of prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 14, 2013 Category: Cancer & Oncology Source Type: news
18-Year Study Finds Drug Cut Prostate Cancer Risk
Follow-up focused on finasteride, the active ingredient in Proscar and hair-loss drug Propecia (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - August 14, 2013 Category: Cancer & Oncology Source Type: news
Merck Profit Plunges 50% as Generics Cut Into Sales
This year the company has been hurt by plunging sales for Singulair, Maxalt, Propecia and Clarinex. (Source: NYT Health)
Source: NYT Health - July 30, 2013 Category: Consumer Health News Authors: By THE ASSOCIATED PRESS Tags: Company Reports Drugs (Pharmaceuticals) Merck & Company Inc Generic Brands and Products Source Type: news
Clinical Study of Post-Finasteride Syndrome Launched at Brigham and Women's Hospital
The Post-Finasteride Syndrome Foundation today announced the funding of a major clinical study on post-finasteride syndrome (PFS) at Brigham and Women’s Hospital (BWH), a teaching affiliate of Harvard Medical School. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - July 1, 2013 Category: Pharmaceuticals Source Type: news
